Shimadzu and Kobe University Jointly Identify Key Proteins in Kidney Cancer.
Using Shimadzu's proprietary NBS (2-nitrobenzensulfenyl) reagents, the two partners have discovered 106 different types of protein in cancer cells and 28 different types of protein in normal cells, and identified the structures of these proteins.
The partners plan to proceed with research on the newly identified proteins, in particular those that increase in cancer cells, aiming to elucidate a mechanism and develop a method to treat kidney cancer.
Details of the research will be presented at the 20th IUBMB International Congress of Biochemistry and Molecular Biology to be held this month and the 23rd Annual Meeting of the Japan Society for Therapeutic Drug Monitoring to be held in July.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Jun 16, 2006|
|Previous Article:||Sanyo Electric, Institut Technologi Bandung to Collaborate in Developing Water Purification Solution.|
|Next Article:||Ono Pharmaceutical, Banyu Pharmaceutical Jointly Confirm Hypoglycemic Effect of DPP4 Inhibitor Sitagliptin.|